A child gets a malaria vaccination at Yala Sub-County hospital, in Yala October 7, 2021. - World Health Organization (WHO) approved using the malaria vaccine, Mosquirix, on children between 5-month to 5-year old in sub-Saharan Africa and other parts with moderate to high malaria transmission after the malaria vaccine implementation programme (MVIP) in Ghana, Kenya, and Malawi since 2019. (Photo by Brian Ongoro / AFP)
A child gets a malaria vaccination at Yala Sub-County hospital, in Yala October 7, 2021. - World Health Organization (WHO) approved using the malaria vaccine, Mosquirix, on children between 5-month to 5-year old in sub-Saharan Africa and other parts with moderate to high malaria transmission after the malaria vaccine implementation programme (MVIP) in Ghana, Kenya, and Malawi since 2019. (Photo by Brian Ongoro / AFP)
The kids, between three and 59 months old from 17 local councils, are to be administered seasonal malaria chemoprevention drugs.
While flagging off the therapy yesterday in Damaturu, the Director for Immunisation and Disease Control, YPHMB, Dr. Umar Chiroma, disclosed that the anti-malarial therapy was approved and supported by WHO to save lives.
According to him, exercise can prevent children from contracting malaria.
Subscribe to the Guardian today and never miss the stories that shape your Business